Pursuant to section 106(1) of the Medicines Act 1981,
I, Mark Richards, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health, acting under delegated authority, hereby declare that:
The medicine listed in the Schedule to this notice is classified as a prescription medicine.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) preparations and admixtures containing any proportion of any substance listed in the notice.
(b) salts and esters of any substance listed in the notice.
(c) preparations or extracts of biological materials listed in the notice.
(d) salts or oxides of elements listed in the notice.
Unless specific reference is made otherwise, every reference to a medicine applies:
(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and
(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule
Prescription Medicines
Oseltamivir; except when sold in a pharmacy between the months of May to September inclusive, or for the duration of the Influenza A (H1N1) Pandemic, by a registered pharmacist who is satisfied that the medicine is for the treatment of a consumer who is resident in New Zealand, is 12 years of age or more, and currently has symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by
a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic.
All previous declarations with respect to the classification
of Oseltamivir, published in the New Zealand Gazette,
12 February 2009, No. 16, page 405 and Supplement to the New Zealand Gazette, 22 June 2009, No. 91, page 2069, are hereby revoked.
Dated this 3rd day of July 2009.
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health.